EA201890525A1 - Кристаллическая форма 2-(2,6-дихлорфенил)-1-[(1s,3r)-3-(гидроксиметил)-5-(3-гидрокси-3-метилбутил)-1-метил-3,4-дигидроизохинолин-2(1h)-ил]этанона для лечения болезни паркинсона - Google Patents
Кристаллическая форма 2-(2,6-дихлорфенил)-1-[(1s,3r)-3-(гидроксиметил)-5-(3-гидрокси-3-метилбутил)-1-метил-3,4-дигидроизохинолин-2(1h)-ил]этанона для лечения болезни паркинсонаInfo
- Publication number
- EA201890525A1 EA201890525A1 EA201890525A EA201890525A EA201890525A1 EA 201890525 A1 EA201890525 A1 EA 201890525A1 EA 201890525 A EA201890525 A EA 201890525A EA 201890525 A EA201890525 A EA 201890525A EA 201890525 A1 EA201890525 A1 EA 201890525A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- methylbutyl
- dichlorophenyl
- hydroxymethyl
- hydroxy
- methyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
- C07D217/14—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals
- C07D217/16—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring other than aralkyl radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562245391P | 2015-10-23 | 2015-10-23 | |
PCT/US2016/057447 WO2017070068A1 (en) | 2015-10-23 | 2016-10-18 | Crystalline form of 2-(2,6-dichlorophenyl)-1-[(1s,3r)-3-(hydroxymethyl)-5-(3-hydroxy-3-methylbutyl)-1-methyl-3,4-dihydroisoquinolin-2(1h)-yl]ethanone for the treatment of parkinson's disease |
Publications (1)
Publication Number | Publication Date |
---|---|
EA201890525A1 true EA201890525A1 (ru) | 2018-09-28 |
Family
ID=57233858
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA201890525A EA201890525A1 (ru) | 2015-10-23 | 2016-10-18 | Кристаллическая форма 2-(2,6-дихлорфенил)-1-[(1s,3r)-3-(гидроксиметил)-5-(3-гидрокси-3-метилбутил)-1-метил-3,4-дигидроизохинолин-2(1h)-ил]этанона для лечения болезни паркинсона |
Country Status (13)
Country | Link |
---|---|
CN (1) | CN108137506A (es) |
AR (1) | AR106332A1 (es) |
AU (1) | AU2016341115A1 (es) |
CA (1) | CA2999332A1 (es) |
DO (1) | DOP2018000103A (es) |
EA (1) | EA201890525A1 (es) |
EC (1) | ECSP18030976A (es) |
IL (1) | IL257872A (es) |
MX (1) | MX2018004794A (es) |
PE (1) | PE20181296A1 (es) |
PH (1) | PH12018500859A1 (es) |
TW (1) | TW201725199A (es) |
WO (1) | WO2017070068A1 (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI725408B (zh) * | 2018-04-20 | 2021-04-21 | 美商美國禮來大藥廠 | 多巴胺d1受體正向異位調節劑 |
JP2022514659A (ja) * | 2018-12-18 | 2022-02-14 | イーライ リリー アンド カンパニー | ドーパミン作動性cns障害の治療におけるly3154207の使用のための用量レジメン |
TWI825323B (zh) * | 2019-06-18 | 2023-12-11 | 美商美國禮來大藥廠 | 用於製備2-(2,6-二氯苯基)-1-[(1s,3r)-3-(羥甲基)-5-(3-羥基-3-甲基丁基)-1-甲基-3,4-二氫異喹啉-2(1h)-基]乙烯酮之方法及中間物 |
WO2022192231A1 (en) | 2021-03-08 | 2022-09-15 | Eli Lilly And Company | Use of mevidalen and other d1 positive allosteric modulators in the treatment of hallucinations and dementia-related psychosis |
EP4304577A1 (en) | 2021-03-09 | 2024-01-17 | Eli Lilly And Co. | Use of mevidalen and other d1 positive allosteric modulators for slowing of parkinson's disease progression |
CN113264926A (zh) * | 2021-05-31 | 2021-08-17 | 东北林业大学 | 一种牡荆素与利血平的共晶及其制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5236934A (en) * | 1992-08-26 | 1993-08-17 | E. I. Du Pont De Nemours And Company | 1,2,3,4-tetrahydroisoquinolines useful in the treatment of CNS disorders |
BRPI0808525A2 (pt) * | 2007-03-01 | 2014-08-19 | Janssen Pharmaceutica Nv | Compostos de tetraidroisoquinolina como moduladors do receptor de histamina h3 |
US20120252853A1 (en) * | 2011-04-01 | 2012-10-04 | H. Lundbeck A/S | Positive allosteric modulators of nicotinic acetylcholine receptor |
JO3316B1 (ar) * | 2013-05-30 | 2019-03-13 | Lilly Co Eli | مركبات 3، 4-داي هيدرو أيزو كوينولين -2(1h)-يل |
-
2016
- 2016-10-13 AR ARP160103122A patent/AR106332A1/es unknown
- 2016-10-14 TW TW105133203A patent/TW201725199A/zh unknown
- 2016-10-18 CA CA2999332A patent/CA2999332A1/en not_active Abandoned
- 2016-10-18 EA EA201890525A patent/EA201890525A1/ru unknown
- 2016-10-18 PE PE2018000570A patent/PE20181296A1/es not_active Application Discontinuation
- 2016-10-18 AU AU2016341115A patent/AU2016341115A1/en not_active Abandoned
- 2016-10-18 CN CN201680061907.6A patent/CN108137506A/zh active Pending
- 2016-10-18 MX MX2018004794A patent/MX2018004794A/es unknown
- 2016-10-18 WO PCT/US2016/057447 patent/WO2017070068A1/en active Application Filing
-
2018
- 2018-03-05 IL IL257872A patent/IL257872A/en unknown
- 2018-04-20 EC ECIEPI201830976A patent/ECSP18030976A/es unknown
- 2018-04-20 DO DO2018000103A patent/DOP2018000103A/es unknown
- 2018-04-20 PH PH12018500859A patent/PH12018500859A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
TW201725199A (zh) | 2017-07-16 |
AR106332A1 (es) | 2018-01-03 |
CN108137506A (zh) | 2018-06-08 |
WO2017070068A1 (en) | 2017-04-27 |
DOP2018000103A (es) | 2018-10-31 |
CA2999332A1 (en) | 2017-04-27 |
AU2016341115A1 (en) | 2018-04-12 |
ECSP18030976A (es) | 2018-05-31 |
MX2018004794A (es) | 2018-06-19 |
IL257872A (en) | 2018-06-03 |
PH12018500859A1 (en) | 2018-10-29 |
PE20181296A1 (es) | 2018-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201890525A1 (ru) | Кристаллическая форма 2-(2,6-дихлорфенил)-1-[(1s,3r)-3-(гидроксиметил)-5-(3-гидрокси-3-метилбутил)-1-метил-3,4-дигидроизохинолин-2(1h)-ил]этанона для лечения болезни паркинсона | |
PE20152032A1 (es) | Compuestos de 3,4-dihidroisoquinolin-2(1h)-il | |
MX2021013550A (es) | Formas solidas de derivados de isoquinolinona, proceso de fabricacion, composiciones que las contienen y metodos de uso de las mismas. | |
CL2015002529A1 (es) | Compuestos de tetrahidropirrolotiazina | |
WO2015132799A3 (en) | Heterocyclic compounds | |
EA201691872A1 (ru) | Гетероциклические соединения для применения в лечении pi3k-гамма-опосредованных расстройств | |
EP3778605A3 (en) | Lrrk2 inhibitors and methods of making and using the same | |
IL278178A (en) | Use of pilocarpine hydrochloride to treat eye disorder | |
MA44759B1 (fr) | Forme polymorphe de n-(6-(2-hydroxypropan-2-yl)-2-[2-(méthylsulfonyl)éthyl]-2h-indazol-5-yl)-6-(trifluorométhyl)pyridine-2-carboxamide | |
EA201691997A1 (ru) | Производные 2,4-тиазолинидона в лечении расстройств центральной нервной системы | |
WO2018067520A3 (en) | Therapeutic agents and methods: | |
NZ746468A (en) | Methods of treating ocular conditions | |
EA201691831A1 (ru) | Гетероароматические соединения и их применение в качестве допаминовых d1 лигандов | |
EA201691788A1 (ru) | Гетероароматические соединения и их применение в качестве допаминовых d1 лигандов | |
MA39450A1 (fr) | Sels pharmaceutiquement acceptables d'énantiomères de pirlindole s'utilisant en médecine | |
CO2017007691A2 (es) | Inhibidores de la β-secretasa derivados de la 5-amino-3-(5-(3-isoxazol-5-il)-3-(fluorometil)-6,6-dimetil-1-(metilimino)-3,6-dihidro-2h-1,4-tiazina o 5-amino-3-(5-(1h-1,2,3-triazol-4-il)-2-fluorofenil)-6,6-dimetil-1-(metilimino)-3,6-dihidro-2h-1,4-tiazina composiciones que los comprenden y métodos de elaboración | |
EA201792558A1 (ru) | Противогрибковый 4-(4-(4-(((3r,5r)-5-((1h-1,2,4-триазол-1-ил)метил)-5-(2,4-дифторфенил)тетрагидрофуран-3-ил)метокси)-3-метилфенил)пиперазин-1-ил)-n-(2-гидроксициклогексил)бензамид или его фармацевтически приемлемая соль | |
NZ735249A (en) | Tetrahydrofurane-fused aminohydrothiazine derivatives which are useful in the treatment of alzheimer’s disease | |
BR112018017058A2 (pt) | 6-amino-5-fluoro-5-(fluorometil)-2,3,4,5-tetra-hidropiridin-2-il-fenil-5-(metóxi-d3)-pirazina-2-carboxamidas e derivados fluorados do mesmo como inibidores de bace1 | |
MA40345A (fr) | Nouvelle forme polymorphe de chlorhydrate de n-[2-(6-fluoro-lh-indol-3-yl)éthyl]-3-(2,2,3,3-tétrafluoropropoxy) benzylamine pour le de traitement de la maladie d'alzheimer | |
EA202193105A1 (ru) | Способы и промежуточные соединения для получения 2-(2,6-дихлорфенил)-1-[(1s,3r)-3-(гидроксиметил)-5-(3-гидрокси-3-метилбутил)-1-метил-3,4-дигидроизохинолин-2(1h)-ил]этенона | |
EA202190043A2 (ru) | Замещенные гетероциклические производные как ингибиторы циклин-зависимой киназы (cdk) | |
EA201692221A1 (ru) | Фармацевтическая композиция для профилактики и лечения заболеваний, связанных с повышенной активностью индуцируемой синтазы окиси азота |